Physician profile
Joshua Marcus
NPI 1609010719
$141,921.91
in general payments reported to CMS, 2019-2025
33 companies · $25K in 2025
The $25K reported for 2025 was more than what 91% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,587 · 2020: $1,151 · 2021: $12K · 2022: $21K · 2023: $43K · 2024: $35K · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $85K · Food and Beverage: $9,775 · Travel and Lodging: $4,789 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,200 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $85,131.56 |
| Food and Beverage | $9,775.27 |
| Travel and Lodging | $4,789.24 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,200.00 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $65,187.71 | 2021-2025 | |
| Globus Medical, INC. | $33,531.82 | 2021-2025 | Tlif, Rise-L . Rise-L A/L, Rise |
| Premia Spine, LTD. | $17,581.56 | 2025 | Tops |
| Depuy Synthes Products, INC. | $10,537.56 | 2021 | |
| Depuy Synthes Sales INC. | $3,134.34 | 2019-2025 | Velys, Embotrap, Fibergraft Bg Morsels |
| Boston Scientific Corporation | $2,772.52 | 2019-2025 | Enroute Transcarotid Stent |
| Microvention, INC. | $2,604.31 | 2019-2023 | Stent, Web Aneurysm Embolization System |
| Medtronic USA, INC. | $1,459.86 | 2019-2020 | |
| Penumbra, INC. | $947.80 | 2019-2025 | Penumbra Coil 400, Red 72, Penumbra System |
| Route 92 Medical, INC. | $685.25 | 2024-2025 | 8f Base Camp Sheath System |
| Nevro Corp. | $677.10 | 2019-2024 | Senza |
| Stryker Corporation | $508.88 | 2021-2025 | Everest Spinal System, Capri Corpectomy Cage System, Axs Vecta 71 |
| Saluda Medical Americas, INC. | $474.50 | 2024-2025 | Evoke |
| Medtronic, INC. | $424.89 | 2021-2025 | Unid_pass, Intellis Adaptivestim, Pipeline |
| Orthofix Medical, INC. | $215.95 | 2019-2024 | Spinal-Stim, Spinal-Stim |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $175.48 | 2023-2024 | Cmf |
| Cardiva Medical, INC. | $149.13 | 2024-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f |
| Contego Medical, INC | $122.40 | 2025 | |
| Imperative Care, INC | $119.73 | 2025 | Zoom 88-T Large Distal Platform |
| Csl Behring | $89.36 | 2023 | Kcentra |
| Cerapedics INC. | $87.92 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| E.R. Squibb & Sons, L.L.C. | $87.66 | 2019 | |
| Ossdsign USA Incorporated | $77.29 | 2023 | |
| 4web, INC. | $46.98 | 2024 | Spine Truss System |
| Lemaitre Vascular, INC. | $38.72 | 2025 | Anastoclip Gc 8cm (Medium) |
| Biotronik Nro, INC. | $36.89 | 2025 | Prospera |
| Phenox INC. | $32.64 | 2020 | |
| Nuvasive, INC. | $31.37 | 2019 | |
| Microtransponder, INC. | $30.56 | 2025 | |
| Carlsmed, INC. | $25.52 | 2025 | Aprevo |
| Janssen Pharmaceuticals, INC | $13.20 | 2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $13.01 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$300,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Marcus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.